Solute clearance in CRRT: prescribed dose versus actual delivered dose.
نویسندگان
چکیده
BACKGROUND Substantial efforts have been made toward defining the dose threshold of continuous renal replacement therapy (CRRT) associated with improved survival in critically ill patients with acute kidney injury. Published studies have used prescribed effluent rates, expressed as total effluent volume (TEV) per weight and unit time (mL/kg/h), as a surrogate for dose. The purpose of this study was to compare differences in CRRT dose based on prescribed effluent rate, measured TEV and direct measurement of urea and creatinine clearance. METHODS We analyzed data that had been prospectively collected on 200 patients enrolled in a randomized trial comparing survival with a prescribed effluent rate of 20 mL/kg/h (standard dose) to 35 mL/kg/h (high dose) using pre-dilution continuous venovenous hemodiafiltration (CVVHDF). Filters were changed every 72 h. Blood urea nitrogen (BUN), serum creatinine (SCr), effluent urea nitrogen (EUN) and effluent creatinine (ECr) were collected daily. Actual delivered dose was calculated as: (EUN/BUN)*TEV for urea and (ECr/SCr)*TEV for creatinine. Data were available for 165 patients. RESULTS In both groups, prescribed dose differed significantly from the measured TEV dose (P < 0.001). In the standard dose group, there was no difference between the measured TEV dose and actual delivered urea and creatinine clearances. However, in the high-dose group, measured TEV dose differed significantly from delivered urea clearance by 7.1% (P < 0.001) and creatinine clearance by 13.9% (P < 0.001). CONCLUSIONS Dose based on prescribed effluent rate or measured TEV is a poor substitute for actual CVVHDF creatinine and urea clearance.
منابع مشابه
Time points may also count in assessment of the difference between prescribed and delivered dose.
Sir, I read with great interest the article by Lyndon et al. [1]. They analyzed data of a prospective trial [2] to investigate the difference between prescribed and delivered continuous renal replacement therapy (CRRT) doses and concluded that there was a large gap between the delivered and prescribed dose. This is important for interventional studies comparing intensive versus less intensive d...
متن کاملQuantification and Dosing of Renal Replacement Therapy in Acute Kidney Injury: A Reappraisal.
BACKGROUND/AIMS Delivered dialysis therapy is routinely measured in the management of patients with end-stage renal disease; yet, the quantification of renal replacement prescription and delivery in acute kidney injury (AKI) is less established. While continuous renal replacement therapy (CRRT) is widely understood to have greater solute clearance capabilities relative to intermittent therapies...
متن کاملDistinction between induction and maintenance dosing in continuous renal replacement therapy
replacement therapy (CRRT), Dr Prowle and colleagues concluded that patients should be prescribed 20 to 25 ml/kg/h [1]. However, by averaging CRRT dose over time, studies in this area obfuscate the benefi ts of appropriately higher dose therapy early in the course of illness, potentially misguiding clinicians into blindly adopting a ‘one-size-fi ts-all’ approach and consequently prescribing ina...
متن کاملOptimal Mode of clearance in critically ill patients with Acute Kidney Injury (OMAKI) - a pilot randomized controlled trial of hemofiltration versus hemodialysis: a Canadian Critical Care Trials Group project
INTRODUCTION Among critically ill patients with acute kidney injury (AKI) needing continuous renal replacement therapy (CRRT), the effect of convective (via continuous venovenous hemofiltration [CVVH]) versus diffusive (via continuous venovenous hemodialysis [CVVHD]) solute clearance on clinical outcomes is unclear. Our objective was to evaluate the feasibility of comparing these two modes in a...
متن کاملLongitudinal hemodiafilter performance in modeled continuous renal replacement therapy.
BACKGROUND/AIMS With advanced anticoagulation, many institutions operate continuous renal replacement therapy (CRRT) circuits longer than manufacturers' recommendations. This extended use may change hemodiafilter performance and clearance properties. However, hemodiafilter performance over time has not been assessed. We investigated solute clearance over time in modeled CRRT. METHODS In vitro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
دوره 27 3 شماره
صفحات -
تاریخ انتشار 2012